{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:35:02Z","timestamp":1778715302608,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bmcl.2023.129432","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T19:01:23Z","timestamp":1692126083000},"page":"129432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Modification of N-hydroxycytidine yields a novel lead compound exhibiting activity against the Venezuelan equine encephalitis virus"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5106-3832","authenticated-orcid":false,"given":"Isaac L.","family":"Downs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"David Ordonez Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna P.","family":"Kota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena S.","family":"Shirsekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekha G.","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7183-9597","authenticated-orcid":false,"given":"Vladislav A.","family":"Litosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2023.129432_b0005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2174\/1568026615666150915111933","article-title":"Base-Modified Nucleosides as Chemotherapeutic Agents: Past and Future","volume":"16","author":"Burke","year":"2016","journal-title":"Curr Topics Med Chem"},{"key":"10.1016\/j.bmcl.2023.129432_b0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10555-007-9044-4","article-title":"The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs","volume":"26","author":"Zhang","year":"2007","journal-title":"Cancer Met Rev"},{"key":"10.1016\/j.bmcl.2023.129432_b0015","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00018-002-8511-x","article-title":"Structure and function of cellular deoxyribonucleoside kinases","volume":"59","author":"Eriksson","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bmcl.2023.129432_b0020","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.leukres.2008.03.010","article-title":"Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues","volume":"32","author":"Chen","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.bmcl.2023.129432_b0025","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1021\/bi00134a027","article-title":"Inhibition of DNA primase and polymerase.alpha. by arabinofuranosylnucleoside triphosphates and related compounds","volume":"31","author":"Kuchta","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2023.129432_b0030","first-page":"2386","article-title":"Effects of 2-Chloro-9-(2-deoxy-2-fluoro-\u03b2-d-arabinofuranosyl)adenine on K562 Cellular Metabolism and the Inhibition of Human Ribonucleotide Reductase and DNA Polymerases by Its 5\u2032-Triphosphate","volume":"51","author":"Parker","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmcl.2023.129432_b0035","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.1994.12.10.2035","article-title":"Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil","volume":"12","author":"Peters","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bmcl.2023.129432_b0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/bi00829a017","article-title":"Purification and properties of 5-phosphoribosylpyrophosphate amidotransferase from adenocarcinoma 755 cells","volume":"8","author":"Hill","year":"1969","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2023.129432_b0045","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/0006-2952(86)90623-4","article-title":"Concurrent unilateral chromatid damage and DNA strand breakage in response to 6-thioguanine treatment","volume":"35","author":"Fairchild","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2023.129432_b0050","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.273.5278.1109","article-title":"Role of Postreplicative DNA Mismatch Repair in the Cytotoxic Action of Thioguanine","volume":"273","author":"Swann","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2023.129432_b0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hlca.19940770109","article-title":"Nitrostyrene Derivatives of Adenosine 5\u2032-Glutarates Modified with an Alkyl Spacer and their inhibitory activity on epidermal growth factor receptor protein tyrosine kinase","volume":"77","author":"Peterli","year":"1994","journal-title":"Helv Chim Acta"},{"key":"10.1016\/j.bmcl.2023.129432_b0060","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.ejmech.2011.01.048","article-title":"Synthesis of purin-2-yl and purin-6-yl-aminoglucitols as C-nucleosidic ATP mimics and biological evaluation as FGFR3 inhibitors","volume":"46","author":"Tak-Tak","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129432_b0065","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1182\/blood.V96.10.3537","article-title":"Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria","volume":"96","author":"Genini","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bmcl.2023.129432_b0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10637-009-9229-5","article-title":"Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial. Invest","volume":"28","author":"Lee","year":"2010","journal-title":"New Drugs"},{"key":"10.1016\/j.bmcl.2023.129432_b0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3816\/CBC.2010.n.020","article-title":"A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy","volume":"10","author":"Pippen","year":"2010","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.bmcl.2023.129432_b0080","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/bjc.1998.321","article-title":"A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer","volume":"77","author":"Ando","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bmcl.2023.129432_b0085","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1200\/JCO.2011.37.9289","article-title":"Sudden Death Related to Toxicity in a Patient on Capecitabine and Irinotecan Plus Bevacizumab Intake: Pharmacogenetic Implications","volume":"30","author":"Dahan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bmcl.2023.129432_b0090","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2125.2010.03686.x","article-title":"Lethal outcome of 5-fluorouracil infusion in a patient with a total DPD deficiency and a double DPYD and UTG1A1 gene mutation","volume":"70","author":"Mounier-Boutoille","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bmcl.2023.129432_b0095","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3109\/0284186X.2010.491088","article-title":"Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma","volume":"50","author":"Willemsen","year":"2011","journal-title":"Acta Oncolog."},{"key":"10.1016\/j.bmcl.2023.129432_b0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/CBM-2009-0111","article-title":"Cytotoxic studies of anti-neoplastic drugs on human lymphocytes \u2013 In vitro studies","volume":"5","author":"Krishna","year":"2009","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.bmcl.2023.129432_b0105","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00280-011-1666-0","article-title":"5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases","volume":"68","author":"Cordier","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bmcl.2023.129432_b0110","unstructured":"Sun, J.; Damaraju, V. L.; Cass, C. E.; Sawyer, M. B. Inhibition of nucleoside transporters by tyrosine kinase inhibitors and its effects on chemotherapy efficacy. Cancer Cell Microenv 2014, 1, e389. 10.14800\/ccm.389."},{"key":"10.1016\/j.bmcl.2023.129432_b0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.13-S1-5","article-title":"Systemic Chemotherapy for Advanced Non-Small Cell Lung Cancer: Recent Advances and Future Directions","volume":"13","author":"Ramalingam","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.bmcl.2023.129432_b0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ctrv.2012.07.001","article-title":"Selective sensitization of tumors to chemotherapy by marine-derived lipids: A review","volume":"39","author":"Hajjaji","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bmcl.2023.129432_b0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1158\/1078-0432.CCR-13-2293","article-title":"Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity","volume":"20","author":"Damaraju","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmcl.2023.129432_b0130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1158\/1078-0432.CCR-10-2159","article-title":"A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer","volume":"17","author":"Lolkema","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmcl.2023.129432_b0135","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3109\/10428194.2011.636812","article-title":"Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial","volume":"53","author":"Cannas","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bmcl.2023.129432_b0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ddr.21752","article-title":"CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections","volume":"82","author":"Meeran","year":"2021","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmcl.2023.129432_b0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jiac.2020.12.021","article-title":"Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19","volume":"27","author":"Yamazaki","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.bmcl.2023.129432_b0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40262-020-00916-9","article-title":"Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV","volume":"60","author":"Calcagno","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bmcl.2023.129432_b0155","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/jvh.13222","article-title":"An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate","volume":"27","author":"Lim","year":"2020","journal-title":"J. Viral Hep."},{"key":"10.1016\/j.bmcl.2023.129432_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104597","article-title":"The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection","volume":"171","author":"Painter","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2023.129432_b0165","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.3390\/v7122934","article-title":"Identification of a new ribonucleoside inhibitor of Ebola virus replication","volume":"7","author":"Reynard","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.bmcl.2023.129432_b0170","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3851\/IMP2229","article-title":"Antiviral activity of nucleoside analogues against norovirus","volume":"17","author":"Costantini","year":"2012","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.bmcl.2023.129432_b0175","doi-asserted-by":"crossref","first-page":"eabb5883","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bmcl.2023.129432_b0180","doi-asserted-by":"crossref","first-page":"28115","DOI":"10.1039\/D0CP05297C","article-title":"Role of different tautomers in the base-pairing abilities of some of the vital antiviral drugs used against COVID-19","volume":"22","author":"Jena","year":"2020","journal-title":"PCCP"},{"key":"10.1016\/j.bmcl.2023.129432_b0185","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1093\/nar\/gkl761","article-title":"Template properties of mutagenic cytosine analogues in reverse transcription","volume":"34","author":"Suzuki","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2023.129432_b0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0027-5107(93)90102-L","article-title":"Comparison of the spectra of genetic damage in N4-hydroxycytidine-induced ad-3 mutations between nucleotide excision repair-proficient and -deficient heterokaryons of Neurospora crassa","volume":"285","author":"De Serres","year":"1993","journal-title":"Mutation Res."},{"key":"10.1016\/j.bmcl.2023.129432_b0195","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1093\/nar\/11.15.5223","article-title":"N4-Aminocytidine, a nucleoside analog that has an exceptionally high mutagenic activity","volume":"11","author":"Negishi","year":"1983","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2023.129432_b0200","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijpharm.2018.06.027","article-title":"Enhanced nanoparticle uptake into virus infected cells: Could nanoparticles be useful in antiviral therapy?","volume":"547","author":"Abo-zeid","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.bmcl.2023.129432_b0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bmc.2009.11.013","article-title":"Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: Chitosan-O-isopropyl-5\u2032-O-d4T monophosphate conjugate","volume":"18","author":"Yang","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2023.129432_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114121","article-title":"Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition","volume":"231","author":"Sanna","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129432_b0215","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1093\/nar\/gkq1293","article-title":"Improved nucleotide selectivity and termination of 3\u2032-OH unblocked reversible terminators by molecular tuning of 2-nitrobenzyl alkylated HOMedU triphosphates","volume":"39","author":"Litosh","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2023.129432_b0220","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1093\/nar\/gkm689","article-title":"Termination of DNA Synthesis by N6-alkylated, not 3\u2032-alkylated, Photocleavable 2\u2032-Deoxyadenosine Triphosphates","volume":"35","author":"Wu","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2023.129432_b0225","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/anie.201106516","article-title":"Stereochemistry of Benzylic Carbon Substitution Coupled with Ring Modification of 2-Nitrobenzyl Groups as Key Determinants for Fast-Cleaving Reversible Terminators","volume":"51","author":"Stupi","year":"2012","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2023.129432_b0230","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.bmc.2015.01.057","article-title":"Base-modified thymidines capable of terminating DNA synthesis are novel drug candidates with activity in cancer cells","volume":"23","author":"Borland","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2023.129432_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2020.131705","article-title":"Stereochemistry of the \u03b1-carbon in benzylic modifying moiety attached at the C-5 end of thymidine affects the potency of a newly identified anti-cancer lead nucleoside","volume":"76","author":"Bercz","year":"2020","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2023.129432_b0240","first-page":"3","article-title":"Base-modified thymidine and thymine analogs with low cytotoxicity effectively obstruct DNA replication in papovaviridae","volume":"4","author":"Borland","year":"2016","journal-title":"BioChem Comp"},{"key":"10.1016\/j.bmcl.2023.129432_b0245","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.carres.2011.07.026","article-title":"Synthesis of various 5-alkoxymethyluracil analogs and structure-cytotoxic activity relationship study","volume":"346","author":"Brulikova","year":"2011","journal-title":"Carbohydrate Res"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X23003104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X23003104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:48:32Z","timestamp":1760773712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X23003104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":49,"alternative-id":["S0960894X23003104"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129432","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modification of N-hydroxycytidine yields a novel lead compound exhibiting activity against the Venezuelan equine encephalitis virus","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129432"}}